RxDoctor Payments DataLook up a doctor →

Lee Stein, MD

Neurology · Cordova, TNNPI 1558392233

Payments from drug & device makers

$22,565,835in general payments, 2019–2025

Across 1,694 payments — averaging $13,321 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$8.4M
  • Biogen$7.7M
  • Eisai Inc.$4.8M
  • Genentech, Inc.$1.3M
  • Novartis$192K
  • Sanofi$118K
  • plus $109K from 54 others
$4,590in research payments, 2019–2025

Across 3 payments — averaging $1529.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$5K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly16$8,372,317
Biogen90$7,716,491
Eisai Inc.241$4,797,792
Genentech, Inc.93$1,260,573
Novartis120$191,919
Sanofi70$117,741
Genentech USA, Inc.71$39,978
Teva Pharmaceuticals USA, Inc.61$21,878
EMD Serono, Inc.110$14,184
Bristol Myers Squibb49$11,453
AbbVie(2 entities)208$6,912
Mallinckrodt Enterprises LLC8$3,502
E.r. Squibb & Sons, L.L.C.1$1,200
Amgen(2 entities)61$1,109
UCB, Inc.32$749
Pfizer77$699
Argenx US, Inc.27$553
AstraZeneca(2 entities)24$460
Amneal Pharmaceuticals LLC20$348
TG Therapeutics, Inc.14$345
ANI Pharmaceuticals, Inc.10$330
Acorda Therapeutics, Inc18$327
Neurocrine Biosciences, Inc.15$321
Lilly USA, LLC21$304
Modernatx, Inc.2$265
MDD US Operations, LLC17$257
Harmony Biosciences LLC10$244
Grifols USA, LLC14$244
Acadia Pharmaceuticals Inc14$232
Alnylam Pharmaceuticals Inc.12$231
Otsuka America Pharmaceutical, Inc.16$221
Avanir Pharmaceuticals, Inc.13$217
Lundbeck LLC12$216
Johnson & Johnson(2 entities)7$209
CSL Behring14$209
Supernus Pharmaceuticals, Inc.17$176
Abbott5$170
Akcea Therapeutics, Inc.7$148
Jazz Pharmaceuticals Inc.8$143
Banner Life Sciences, LLC7$120
SK Life Science, Inc.7$119
Biohaven Pharmaceutical Holding Company Ltd.8$117
Tanabe Pharma America, Inc.7$112
Neurelis, Inc.6$108
Axsome Therapeutics, Inc.3$76
Adamas Pharmaceuticals, Inc.4$74
C2n Diagnostics, LLC2$53
Mallinckrodt Hospital Products Inc.3$48
Sunovion Pharmaceuticals Inc.3$32
Avion Pharmaceuticals2$31
Takeda Pharmaceuticals U.S.A., Inc.1$30
Scilex Pharmaceuticals Inc.2$30
Biohaven Pharmaceuticals, Inc.2$28
Sumitomo Pharma America, Inc.2$26
Merz Pharmaceuticals, LLC1$25
Nevro Corp.1$23
Vanda Pharmaceuticals Inc.1$21
Catalyst Pharmaceuticals, Inc.1$20
Ipsen Biopharmaceuticals, Inc1$16
Assertio Therapeutics, Inc.1$14

How this compares

$22,565,835 in reported general payments places this provider in the 95th percentile of 361 neurology providers in Tennessee.

See all neurology providers in Tennessee →

Medicare billing

Part B allowed, 2024
$408,245
Medicare patients
564
Services billed
24,260

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Cordova

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →